Clinical Trial Update: "Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)" [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents receiving highly emetogenic chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: COMPLETED